North Dakota SB 2384: A BILL for an Act to provide for a legislative management study relating to vaccines for respiratory syncytial virus and vaccines developed using messenger ribonucleic acid technology.

Status: Second reading, failed to pass, yeas 38 nays 53 (as of 2023-04-04)

State: North Dakota · Session: 68 · Bill: SB 2384

Sponsors: Jeffery J. Magrum, David A. Clemens, Jeff A. Hoverson, Scott Dyk

View North Dakota SB 2384 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.